Abstract:Automated extraction of chemical structures and their bioactivity data is crucial for accelerating drug discovery and enabling data-driven pharmaceutical research. Existing optical chemical structure recognition (OCSR) tools fail to autonomously associate molecular structures with their bioactivity profiles, creating a critical bottleneck in structure-activity relationship (SAR) analysis. Here, we present BioChemInsight, an open-source pipeline that integrates: (1) DECIMER Segmentation and MolVec for chemical structure recognition, (2) Qwen2.5-VL-32B for compound identifier association, and (3) PaddleOCR with Gemini-2.0-flash for bioactivity extraction and unit normalization. We evaluated the performance of BioChemInsight on 25 patents and 17 articles. BioChemInsight achieved 95% accuracy for tabular patent data (structure/identifier recognition), with lower accuracy in non-tabular patents (~80% structures, ~75% identifiers), plus 92.2 % bioactivity extraction accuracy. For articles, it attained >99% identifiers and 78-80% structure accuracy in non-tabular formats, plus 97.4% bioactivity extraction accuracy. The system generates ready-to-use SAR datasets, reducing data preprocessing time from weeks to hours while enabling applications in high-throughput screening and ML-driven drug design (https://github.com/dahuilangda/BioChemInsight).